Company intelligence / Profile preview

Oclassen Pharmaceuticals

San Rafael, California, United Stateswwe2.osc.state.ny.us ↗

Ownership: Private
Development stage: Other

Overview

Oclassen Pharmaceuticals developed and commercialized specialty prescription drugs for dermatology and infectious diseases, including the first patient-applied topical therapy for genital warts ("Condylox"), an oral antibiotic for acne ("Monodox"), and topical corticosteroids. The company also licensed wound care products such as Iodosorb Gel. It was acquired by Watson Pharmaceuticals in 1997.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeTopical therapyOral antibioticCorticosteroid (Small molecule)
Industry: Biotech

Partnerships

Perstorp Pharma – licensing agreement for wound care products

Beyond the preview

Go deeper on Oclassen Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oclassen Pharmaceuticals.

Explore the full profile